Wilshire Laboratories (Private) Limited is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 423 product registrations across 386 distinct molecules. It is the 10th largest registrant in Pakistan by product count, and ranks 7th of 213 in Other Beta-Lactam, Cephalosporins & Penems. Its portfolio is concentrated in Other Beta-Lactam, Cephalosporins & Penems and Antiinflammatory And Antirheumatic Products. DRAP has issued 4 alerts involving its products.
Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.
Products by Wilshire
201 products matched in our catalogue · showing 80 — each with its observed price and DRAP approved ceiling.
DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.
This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.